(Q48425824)

11 February 2018

title

Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage (English)

1 reference

11 February 2018

1 reference

1 reference

Haichen Wang

1

1 reference

11 February 2018

Junling Gao

2

1 reference

11 February 2018

Timothy F Lassiter

3

1 reference

11 February 2018

David L McDonagh

4

1 reference

11 February 2018

Huaxin Sheng

5

1 reference

11 February 2018

David S Warner

6

1 reference

11 February 2018

John R Lynch

7

1 reference

11 February 2018

Daniel T Laskowitz

8

1 reference

11 February 2018

publication date

1 January 2006

1 reference

11 February 2018

published in

Neurocritical Care

1 reference

11 February 2018

volume

5

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

71-78

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1385/ncc:5:1:71

exact match

0 references

cites work

Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration

1 reference

12 December 2020

Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema

1 reference

12 December 2020

Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP.

1 reference

12 December 2020

A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels

1 reference

12 December 2020

Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage

1 reference

12 December 2020

A new model of diffuse brain injury in rats. Part II: Morphological characterization

1 reference

12 December 2020

A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury.

1 reference

12 December 2020

Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage

1 reference

12 December 2020

Levetiracetam. A review of its adjunctive use in the management of partial onset seizures

1 reference

12 December 2020

Intravenous administration of fosphenytoin: options for the management of seizures

1 reference

12 December 2020

Psychiatric adverse events during levetiracetam therapy

1 reference

12 December 2020

Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)

1 reference

12 December 2020

Effective improvement of the cerebral vasospasm after subarachnoid hemorrhage with low-dose nitroglycerin

1 reference

12 December 2020

Potential effects of common drugs on stroke recovery

1 reference

12 December 2020

Guidelines for nonemergency use of parenteral phenytoin products: proceedings of an expert panel consensus process. Panel on Nonemergency Use of Parenteral Phenytoin Products

1 reference

12 December 2020

EPILEPSY AFTER RUPTURED INTRACRANIAL ANEURYSM.

1 reference

12 December 2020

A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics

1 reference

12 December 2020

Phenytoin-induced thrombocytopenia

1 reference

12 December 2020

Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials

1 reference

12 December 2020

A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage

1 reference

12 December 2020

Mouse model of subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis

1 reference

12 December 2020

Phenytoin-induced hepatitis, rhabdomyolysis, and renal dysfunction

1 reference

12 December 2020

Effects of levetiracetam on the production of nitric oxide--an in vivo study

1 reference

12 December 2020

A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures

1 reference

12 December 2020

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

1 reference

12 December 2020

Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage

1 reference

12 December 2020

Epileptic seizures after subarachnoid hemorrhage.

1 reference

12 December 2020

Dilantin hypersensitivity reaction.

1 reference

12 December 2020

Levetiracetam safety profiles and tolerability in epilepsy patients.

1 reference

12 December 2020

The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents

1 reference

12 December 2020

Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs

1 reference

12 December 2020

Anticonvulsant prophylaxis and timing of seizures after aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

1 reference

12 December 2020

Expression of brain-derived neurotrophic factor (BDNF) and inducible nitric oxide synthase (iNOS) in rat astrocyte cultures treated with Levetiracetam.

1 reference

12 December 2020

Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia

1 reference

12 December 2020

Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor

1 reference

12 December 2020

Identifiers

DOI

10.1385/NCC:5:1:71

1 reference

11 February 2018

Dimensions Publication ID

1031949315

0 references

1 reference

11 February 2018